An encapsulated peptide ingredient cannot be classified under the EU microplastics restriction from the word encapsulated alone. The carrier's composition, physical form and relevant test evidence determine the assessment. For a peptide serum project, ask the supplier for a documented conclusion tied to its actual grade and intended use before approving a long-term supply agreement.
Identify the carrier materials
A delivery-system trade name may cover a peptide, carrier materials and a liquid dispersion. Identify those parts separately. A description such as lipid capsule, polymer capsule or liposome helps frame questions, but it does not replace composition data.
Croda describes lipid-based peptide delivery systems as one route for incorporating peptides into cosmetic formulas. That supplier example shows why delivery-system identity matters; it does not establish that another supplier's encapsulated grade has the same composition or regulatory status. [3]
Questions for the ingredient manufacturer
- What are the carrier materials and their chemical identities?
- Which components are polymers, and what physical form do they have in the supplied grade?
- What particle-size information applies, and how was it measured?
- Which evidence supports the supplier's assessment under Regulation (EU) 2023/2055?
- Does that assessment address the proposed cosmetic use and any stated conditions?
Put the transition date in the right category
The European Commission's explanation gives a transition through 16 October 2029 for relevant leave-on cosmetic uses under paragraph 6(d). Its examples distinguish rinse-off cosmetics and make-up, lip and nail products, which have different timelines. A facial serum project should not borrow the later date simply because it sits in a broader beauty range. [1]
The official explanatory guide treats abrasive microbeads as one use of synthetic polymer microparticles; the restriction also covers other uses. The absence of visible scrubbing beads therefore does not settle the assessment. [2]
The transition is useful for supply planning. It is not proof that a particular carrier is within scope, exempt or acceptable in every market. Have the responsible regulatory specialist confirm the current legal text, applicable conditions and any reporting or information obligations.
Ask what an exclusion statement actually relies on
The official guide lists exclusions from the definition, including unmodified natural polymers and polymers meeting its degradation or solubility criteria. A supplier claiming one of these routes should identify the applicable criteria and the supporting evidence. A short sales-sheet description of a material as eco-friendly leaves that question open. [2]
| Supplier statement | Useful follow-up |
|---|---|
| Water soluble | Request the test report, method, conditions and grade identity used to support the relevant criteria. |
| Biodegradable | Ask which accepted evidence supports that conclusion and whether the tested material matches the supplied carrier. |
| Natural carrier | Request chemical identity and a description of modifications relevant to the legal definition. |
| Not in scope | Obtain the reasoned assessment, date, responsible issuer and intended-use assumptions. |
Keep proprietary information under a suitable confidentiality arrangement when necessary. A refusal to share a public formula is different from having no documented regulatory assessment.
Make replacement work a formulation project
If the current carrier needs replacement, compare the candidate on the same active-content basis. Record the peptide loading, carrier contribution, preservation and recommended handling. A change in delivery material may alter clarity, viscosity, texture or package performance. The finished formula needs its own qualification even if the peptide INCI name stays the same.
For example, a hypothetical replacement supplied at half the peptide concentration would require twice the addition level to match the original nominal peptide dose. That also doubles the amount of the replacement carrier introduced. Review the complete formula rather than comparing only the price per kilogram of the two ingredients.
Do not transfer penetration, release or consumer-performance claims from the old grade to the new one without appropriate support. The encapsulated peptide sourcing guide covers technical buying questions beyond this regulatory review.
Set a controlled approval record
- Record the exact ingredient and finished-product category.
- File the supplier assessment and supporting evidence with revision dates.
- Document the brand's regulatory review and outstanding conditions.
- Qualify the candidate in the finished serum and commercial package.
- Agree notification requirements for carrier or manufacturing changes.
Schedule development and packaging decisions against the applicable market date. Avoid writing an unsupported microplastic-free claim while the carrier review is still unresolved. Compliance assessment and consumer-facing claim substantiation are related tasks with different evidence requirements.
Frequently asked questions
Are all encapsulated peptides microplastics?
No. Encapsulation describes a delivery approach. Assessment depends on the carrier's identity, physical characteristics and the applicable regulatory criteria.
Does a biodegradable claim settle EU compliance?
It needs evidence meeting the relevant criteria for the actual material. Ask for the supporting assessment and test documentation.
What date should a conventional leave-on facial serum project consider?
The Commission's explanation identifies a transition through 16 October 2029 for relevant leave-on cosmetic uses. Confirm the exact category, current text and conditions for the product.
Can we keep the same performance claims after replacing the carrier?
Only if the evidence supports the revised ingredient and finished formula. Carrier replacement can change the formula and may change the basis of existing claims.
Sources and scope
Sources checked on 31 October 2026. This is editorial guidance for cosmetic formulation and procurement. Examples are hypothetical unless a source is identified; no original product testing or certification is claimed.
- European Commission: Regulation (EU) 2023/2055 explanatory page
- European Commission technical services: Microplastics Explanatory Guide, Part I, version 1.1
- Croda Beauty: Cosmetic peptides and delivery systems
Regulatory points are market-specific. Confirm the applicable requirements and product assessment before launch. For a correction or a question about the sources, contact Pure Peptide Serum.